VEGFA and neoplasm: Interestingly, we have recently reported that treatments with recombinant vaccinia virus strains (VACV) expressing anti-VEGF antibodies (GLAF-1 or GLAF-2) led to enhanced tumor growth inhibition and vascular disruption in different xenograft models [8,9,17,25,33].